Cholangiocarcinoma Clinical Trials in Shanghai, Shanghai Municipality
12 recruitingShanghai, Shanghai Municipality, China
Showing 1–12 of 12 trials
Recruiting
Phase 2
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Advanced CholangiocarcinomaFGFR2 FusionsGene Rearrangement
Taiho Oncology, Inc.120 enrolled65 locationsNCT05727176
Recruiting
Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA
Cholangiocarcinoma
Shanghai Zhongshan Hospital50 enrolled1 locationNCT07291063
Recruiting
A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
ctDNAGall Bladder CancerIntrahepatic Cholangiocarcinoma (Icc)+3 more
Yingbin Liu, MD, PhD, FACS1,800 enrolled1 locationNCT07176962
Recruiting
Phase 2
HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)
Mixed Hepatocellular-cholangiocarcinoma
Fudan University45 enrolled1 locationNCT07105748
Recruiting
Phase 2
Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma (Icc)
Fudan University56 enrolled1 locationNCT07070700
Recruiting
Early Phase 1
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients
Intrahepatic Cholangiocarcinoma
Shanghai Changzheng Hospital9 enrolled1 locationNCT06583993
Recruiting
Phase 3
Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study
Intrahepatic Cholangiocarcinoma
Shanghai Junshi Bioscience Co., Ltd.480 enrolled1 locationNCT05342194
Recruiting
Phase 2
Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer
Intrahepatic Cholangiocarcinoma
Fudan University25 enrolled1 locationNCT05010681
Recruiting
Phase 2
TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma
Fudan University25 enrolled1 locationNCT04954781
Recruiting
Phase 2
HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC
Intrahepatic Cholangiocarcinoma
Fudan University45 enrolled1 locationNCT06335927
Recruiting
Phase 2
A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma (Icc)
Beijing InnoCare Pharma Tech Co., Ltd.70 enrolled44 locationsNCT05678270
Recruiting
Not Applicable
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University168 enrolled13 locationsNCT04078230